Bilobalide prevents reduction of γ-aminobutyric acid levels and glutamic acid decarboxylase activity induced by 4-O-methylpyridoxine in mouse hippocampus

Life Sciences

Volumn 67, Issue 6, 2000, Pages 709-715

  Sasaki, Keiko ^a,b   Hatta, Shinichi ^a   Wada, Keiji ^b   Ohshika, Hideyo ^a   Haga, Masanobu ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Aminobutyric acid (GABA); 4 O methylpyridoxine; Bilobalide; Ginkgo biloba; Glutamate decarboxylase (GAD)

Indexed keywords

4 AMINOBUTYRIC ACID; BILOBALIDE; GLUTAMATE DECARBOXYLASE; PYRIDOXINE DERIVATIVE; 4 METHOXYMETHYLPYRIDOXINE; 4-METHOXYMETHYLPYRIDOXINE; CYCLOPENTANE DERIVATIVE; DITERPENE; DRUG DERIVATIVE; FURAN DERIVATIVE; GINKGOLIDE; GLUTAMIC ACID; NERVE PROTEIN; PYRIDOXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CONVULSION; DRUG BRAIN LEVEL; DRUG EFFECT; ENZYME ACTIVITY; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC TRANSMISSION; HIPPOCAMPUS; LONG TERM POTENTIATION; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; GINKGO BILOBA; MALE; METABOLISM; NEOSTRIATUM;

ANIMALS; CEREBRAL CORTEX; CYCLOPENTANES; DITERPENES; FURANS; GAMMA-AMINOBUTYRIC ACID; GINKGO BILOBA; GINKGOLIDES; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; HIPPOCAMPUS; MALE; MICE; NEOSTRIATUM; NERVE TISSUE PROTEINS; PYRIDOXINE;

EID: 0034705442     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00657-3     Document Type: Article

References (15)

1. T.J. Biscoe and D.W. Straughan, J. Physiol. 183 341-359 (1966).
2. W. Löscher, Neurochem. Res. 18 485-502 (1993).
3. F.V. Defeudis. Ginkgo Biloba Extract (Egb761) Pharmacological Activities and Clinical Applications, 97-138, Elsevier, Paris (1991).
4. K. Sasaki, S. Hatta, K. Wada, H. Ohshika and M. Haga, Res. Commun. Biol. Psychol. and Psychi. 20 145-156 (1995).
5. K. Sasaki, S. Hatta, M. Haga and H. Ohshika. Eur. J. Pharmacol. 367 165-173 (1999).
6. C. Nitsch and Y. Okada, Brain Res. 105 173-178 (1976).
7. R.W. Horton, A.G. Chapman and B.S. Meldrum, J. Neurochem. 33 745-749 (1979).
8. C. Nitsch, J. Neurochem. 34 822-830 (1980).
9. J.A.M. Van Der Heyden and J. Korf, J. Neurochem. 31 197-203 (1978).
10. T.G. Heffner, A.J. Hartman, and L.S. Seiden, Pharmacol. Biochem. Behav. 13 453-456 (1980).
11. K. Wada, K. Sasaki, K. Miura, M. Yagi, Y. Kubota, T. Matsumoto and M. Haga, Biol. Pharm. Bull. 16 210-212(1993).
12. S.A. Harris, J. Am. Chem. Soc. 62 3203-3205 (1940).
13. M.M. Bradford, Anal. Biochem. 72 248-254 (1976).
14. D.L. Martin and K. Rimvall, J. Neurochem. 60 395-407 (1993).
15. M.G. Erlander, N.J.K. Tillakaratne, S. Feldblum, N. Patel and A.J. Tobin, Neuron. 7 91-100 (1991).